Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection.
about
Ventricular assist devices: pharmacological aspects of a mechanical therapyValue of the first post-transplant biopsy for predicting long-term cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patientsClinical impact of H-Y alloimmunitySubclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.Antibody-mediated rejection: an evolving entity in heart transplantation.Utility of C4d immunostaining in the first year after pediatric and young adult heart transplantation.Association of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients.Mechanisms of chronic cardiac allograft rejectionReport from a consensus conference on antibody-mediated rejection in heart transplantationHeart transplantation research in the next decade--a goal to achieving evidence-based outcomes: National Heart, Lung, And Blood Institute Working GroupAntibody-mediated rejection in heart transplantation: case presentation with a review of current international guidelinesCardiac antibody-mediated rejection.Improving survival during heart transplantation: diagnosis of antibody-mediated rejection and techniques for the prevention of graft injury.Immunosuppression following heart transplantation: prospects and challenges.Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification.Human leukocyte antigens and alloimmunization in heart transplantation: an open debate.Heart transplantation: review.Biomarkers of acute rejection following cardiac transplantation.Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection.Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patientsDonor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?Low serum testosterone is associated with impaired graft function early after heart transplantation.Outcome of antibody-mediated rejection compared to acute cellular rejection after pediatric heart transplantation.Molecular Assessment of Microcirculation Injury in Formalin-Fixed Human Cardiac Allograft Biopsies With Antibody-Mediated Rejection.Corticosteroid wean after heart transplantation-Is there a risk for antibody formation?A survey of current practice for antibody-mediated rejection in heart transplantation.Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens.
P2860
Q27002612-9DB5815D-85DC-40C0-9A97-CDF8AA866E66Q34257142-42F46846-91ED-4134-B5D5-E7EFB01181E1Q35235186-A91566E2-8293-4790-942A-35522F883D35Q35790552-7BE2195A-617D-48C0-BD9D-B9506211C073Q35876250-61C1F9A6-BCBF-4130-B932-B0AD8DF57715Q36488525-7A4C5B3C-6394-4E6B-B4DB-46CDC21ABC61Q37029903-CA9FC696-A6F5-46A8-BF75-ADE12732C85AQ37197706-A2E0DC43-609C-48D2-8CB9-D344B7A0C204Q37313051-85F6A66D-EC39-4067-BB2F-9AE301E498B1Q37524481-5CB6D406-6FC4-4F19-BA73-1EDA581306BDQ37969113-47427653-CF96-4DE3-82D2-93D5D3BD1703Q38002449-F7380F50-89F1-4CC6-ADF5-75174F810DCAQ38032621-7D5BF7F6-D305-48DE-A6A5-7801C04D9244Q38184649-ECCD7EEA-84AF-4C77-BACD-1D3A71AFFF9FQ38210159-65375E02-A487-4DB3-8E4B-B86A08861152Q38246225-22D83837-880D-414D-9372-5E2A25FEFE0DQ38543941-40FFB3B6-9301-41F6-AD98-307E098214A2Q39128537-00F08DE5-C64E-4A58-8796-5E730A51B6E7Q39217968-B0AD786F-DBB4-4C37-BE7B-744FAF245959Q39366396-E21402EB-CAF1-4CFE-83CC-3D3F6FA78091Q42656427-A8D17ABE-8275-4846-A58F-CAFCEEB1C5ECQ44055243-DCB164A3-B00B-4FF8-8E94-ABFDC0E45D92Q48109853-F36F1F12-1E7F-4051-A69B-50700FE9EA79Q48149010-B80A3F59-BDC5-4DC7-AB11-7FDF48BEA324Q48165787-04A53F28-A675-4F97-B440-45953D4A456DQ48297414-0D4BD66C-81C9-47D7-A326-D0A171CF569BQ51256229-9C77AE95-28E2-4F98-84B2-81D89505E0ACQ53227865-5AC7543B-D784-4251-82EF-4C6D98B0A0A4
P2860
Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cardiovascular mortality among ...... d antibody-mediated rejection.
@ast
Cardiovascular mortality among ...... d antibody-mediated rejection.
@en
Cardiovascular mortality among ...... d antibody-mediated rejection.
@nl
type
label
Cardiovascular mortality among ...... d antibody-mediated rejection.
@ast
Cardiovascular mortality among ...... d antibody-mediated rejection.
@en
Cardiovascular mortality among ...... d antibody-mediated rejection.
@nl
prefLabel
Cardiovascular mortality among ...... d antibody-mediated rejection.
@ast
Cardiovascular mortality among ...... d antibody-mediated rejection.
@en
Cardiovascular mortality among ...... d antibody-mediated rejection.
@nl
P2093
P1476
Cardiovascular mortality among ...... nd antibody-mediated rejection
@en
P2093
Abdallah G Kfoury
Bruce B Reid
Dale G Renlund
Feras M Bader
M Elizabeth H Hammond
Melanie D Everitt
Patrick W Fisher
Stavros G Drakos
P304
P356
10.1016/J.HEALUN.2009.04.035
P577
2009-08-01T00:00:00Z